Pelthos Therapeutics Inc.

Healthcare · Biotechnology · United States

Last price 9.4 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 35.99M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Pelthos Therapeutics Inc., a bio-pharmaceutical company, develops and commercializes therapeutic products to help patients with unmet treatment burdens. The company offers ZELSUVMI for the treatment of molluscum contagiosum in adults and children 1 year of age and older; XEPI, (ozenoxacin) cream, a quinolone antimicrobial for the treatment of impetigo due to Staphylococcus aureus or Streptococcus pyogenes in adult and pediatric patients 2 months of age and older; and XEGLYZE, a pediculicide indicated for topical treatment of head lice infestati...